Showing results (271-280 of 323) with videos related to
Sort By:
Pageof 33
Rheumatology (Oxford, England)|October 21, 2025
Injury and local injection and the risk of foot/ankle osteoarthritis: a case-control study in retired UK male professional footballersAhmed Ali Thanoon, Shima Espahbodi, Monirah Ali Shuaib, et al.Arthritis & Rheumatology (Hoboken, N.J.)|January 3, 2024
Weight Loss for Patients With Gout and Concomitant Obesity: A Proof-of-Concept Randomized TrialRobin Christensen, Kristian Zobbe, Sabrina M Nielsen, et al.Journal of Evaluation in Clinical Practice|May 26, 2006
Evidence-based clinical guidelines: a new system to better determine true strength of recommendationEdward Roddy, Weiya Zhang, Michael Doherty, et al.Rheumatology (Oxford, England)|May 17, 2026
Prevalence of foot/ankle osteoarthritis and pain in retired male professional footballers compared to general population male controls: a cross-sectional studyAhmed Ali Thanoon, Shima Espahbodi, Monirah Ali Shuaib, et al.Pain|February 20, 2019
The impact of anxiety on chronic musculoskeletal pain and the role of astrocyte activationJames J Burston, Ana M Valdes, Stephen G Woodhams, et al.Annals of the Rheumatic Diseases|August 8, 2013
The effect of FTO variation on increased osteoarthritis risk is mediated through body mass index: a Mendelian randomisation studyKalliope Panoutsopoulou, Sarah Metrustry, Sally A Doherty, et al.Rheumatology International|November 11, 2021
Intra-articular therapies: patient preferences and professional practices in European countriesJenny de la Torre-Aboki, Jacqueline Uson, Irene Pitsillidou, et al.Arthritis Care & Research|October 30, 2010
Role of the Nav1.7 R1150W amino acid change in susceptibility to symptomatic knee osteoarthritis and multiple regional painAna M Valdes, Nigel K Arden, Frances L Vaughn, et al.Lancet (London, England)|August 25, 2004
Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trialMichael E Farkouh, Howard Kirshner, Robert A Harrington, et al.Molecular Cancer Therapeutics|January 14, 2021
Exosome Surface Display of IL12 Results in Tumor-Retained Pharmacology with Superior Potency and Limited Systemic Exposure Compared with Recombinant IL12Nuruddeen D Lewis, Chang Ling Sia, Katherine Kirwin, et al.Pageof 33